跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREHEVBRIO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PREHEVBRIO
Authorized
STANDARD
PREHEVBRIO
VBI Vaccines Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4eefc080ceb645d1
Company
VBI Vaccines Inc
Type
Standard
Approval Details
Approval Id
4eefc080ceb645d1
Drug Approval Canada Name
PREHEVBRIO
Product Name
PREHEVBRIO
Status
Approved
Status Date
2022-12-06
Din
02533286
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BC01 HEPATITIS B, PURIFIED ANTIGEN
Atc Name
j 07 bc 01
Aig Number
0119570001
Company Name
VBI Vaccines Inc
Company Address
310 Hunt Club Road, Ottawa, Ontario, Canada, K1V 1C1
Company Detail Path
/organization/vbi-vaccines-inc
Company Information
Pharmaceutical Company Name
VBI Vaccines Inc
Country Name
Canada
Province Name
Ontario
City Name
ottawa,ontario,country_ca
Address
201-310 Hunt Club Rd
Active Ingredients
HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)
10 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4eefc080ceb645d1
Type
Standard
Back to Health Canada Approvals